Who should sponsor sleep disorders pharmaceutical ...[J Clin Sleep Med. 2007]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: J Clin Sleep Med. 2007 Dec 15;3(7):671-3. Links

Who should sponsor sleep disorders pharmaceutical trials?

PMID: 18198797 [PubMed - indexed for MEDLINE]

PMCID: PMC2556906

Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Minn Med. 2008 Jun; 91(6):46-7.

[Minn Med. 2008]
Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep?
J Sleep Res. 2008 Sep; 17(3):243-4.

[J Sleep Res. 2008]
Greater incidence of depression with hypnotic use than with placebo.
BMC Psychiatry. 2007 Aug 21; 7:42. Epub 2007 Aug 21.

[BMC Psychiatry. 2007]
Review(S)-Zopiclone Sepracor.
Curr Opin Investig Drugs. 2001 Feb; 2(2):271-3.

[Curr Opin Investig Drugs. 2001]
ReviewPediatric sleep pharmacology.
Semin Pediatr Neurol. 2008 Jun; 15(2):79-90.

[Semin Pediatr Neurol. 2008]
» See reviews... | » See all...

Eszopiclone (Lunesta® )
Eszopiclone is used to treat insomnia (difficulty falling asleep or staying asleep). Eszopiclone is in a class of medications called hypnotics. It works by slowing activity in the brain to allow sleep.
Zolpidem (Ambien, Ambien, Sonata, ...)
How do the newer insomnia drugs compare in effectiveness?
Source: AHFS Consumer Medication Information

Your browsing activity is empty.

Activity recording is turned off.

Display Show